Načítá se...
The Risk of Endophthalmitis Following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials
PURPOSE: To report the incidence of endophthalmitis following intravitreal injection using a standardized injection procedure. DESIGN: Two randomized clinical trials METHODS: Nonpreserved intravitreal triamcinolone acetonide in prefilled syringes (Allergan, Inc., Irvine, CA) was injected intravitrea...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2065757/ https://ncbi.nlm.nih.gov/pubmed/17765429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2007.04.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|